// App-Quantinova.ai

2039 : Association of increased survival in glioblastoma patients treated with dendritic cell vaccinations and temozolomide with increased activity of NK cells and ABCC3 expression.

Researchers

Presenter

  • Gaetano Finocchiaro

Principal Investigators

  • Marica Eoli

  • Elena Anghileri

  • Sara Pessina

  • Simona Frigerio

  • Bianca Pollo

  • Valeria Cuccarini

  • Carlo Antozzi

  • Maura Servida

  • Maria Grazia Bruzzone

  • Eugenio Agostino Parati

  • Serena Pellegatta

Medical Centers

  • Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy

  • Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy

  • Unit of Molecular Neuro-Oncology, Fondazione I.R.C.C.S. Istituto Neurologico C. Besta, Milan, Italy

  • Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Glioblastoma

Biomarkers

  • Natural Killer cells

Drug/Treatment

  • Temozolomide

Outcome

  • N/A

Study Design

  • N/A

Phase

  • I

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved